Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Using New Structural Model, Company Uncovers High-Grade Gold in Quebec

Troilus Gold's most recent drill results at its past-producing Quebec project are discussed in a Stifel GMP report. In a May 15 research note, Stifel GMP analyst Tyron Breytenbach reported that Troilus Gold Corp.'s (TLG:TSX; CHXMF:OTCQB) new model of the past-pro...
Streetwise Reports | June 25, 2020 |

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |

Palladium Surges above $2,400. Is It Sustainable?

A new day, a new record in palladium! Is there any stopping it from reaching another high? What’s next in store for the white metal? If you thought gold had a good year, you were wrong. OK, maybe not wrong, but palladium enjoyed larger gains . Just lo...
Arkadiusz Sieron | January 27, 2020 |

From Cystic Fibrosis to COVID-19: A Medical Solution Like No Other

(Image via Dymedso Inc.) Airway clearance therapy has been a cornerstone of treatments aimed at minimizing the devastating effects of airway obstruction, infection, and inflammation caused by a buildup of mucus in lung conditions … but finding a non-invasive solutio...
Stockhouse Editorial | December 8, 2020 |

Keep Calm, Bear Markets Are Temporary

We may very well be headed for a recession—some economists believe it’s already here —but we’re most definitely in a bear market, normally defined as occurring when stocks are off more than 20 percent from their peak. Not only that, bu...
Frank Holmes | March 18, 2020 |

“Solving” the Global Epidemic of Data Forgery and Cyber Attack

(CLICK IMAGE TO PLAY VIDEO) As data forgery and theft continues to plague businesses and individuals alike, real word, real time solutions are needed to battle the bad actors infiltrating private corporate and personal data. Enter SoLVBL Solutions Inc. ( C...
Dave Jackson | June 10, 2021 |

“Solving” the Global Epidemic of Data Forgery and Cyber Attack.

(CLICK IMAGE TO PLAY VIDEO) As data forgery and theft continues to plague businesses and individuals alike, real word, real time solutions are needed to battle the bad actors infiltrating private corporate and personal data. Enter SoLVBL Solutions Inc. ( C...
Dave Jackson | June 17, 2021 |

Apogee Enterprises Shares Trade Up 12.5% on Q2 Earnings and Yearly Outlook

Shares of Apogee Enterprises are trading higher today after the commercial and architectural glass and framing company announced Q2/20 earnings and updated its estimates for the rest of the year. This morning commercial and architectural glass fabricator and window fr...
Streetwise Reports | September 18, 2019 |

Protalix Shares Trade up 70% Upon Release of Phase 3 Fabry Disease Data

Shares of Protalix Biotherapeutics skyrocketed today on much higher than average volume as the firm announced positive 12-month interim data from its BRIDGE Phase 3 open label switch-over study of pegunigalsidase alfa (PRX-102) for the treatment of Fabry disease. Earl...
Streetwise Reports | October 18, 2019 |

Seplat Petroleum to Acquire Eland Oil & Gas

A glance at the deal is provided in a Pareto Securities report. In an Oct. 15 research report, Pareto Securities analyst Tom Erik Kristiansen reported that this morning, Seplat Petroleum Development Co. Plc (SEPL:LSE) offered to acquire Eland Oil & Gas Plc (ELA:LSE...
Streetwise Reports | October 18, 2019 |
1 2 3 4 5 6 7 8 9 10 ...